Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
Joram Huckriede, Sara Bülow Anderberg, Albert Morales, Femke de Vries, Michael Hultström, Anders Bergqvist, José T Ortiz-Pérez, Jan Willem Sels, Kanin Wichapong, Miklos Lipcsey, Marcel van de Poll, Anders Larsson, Tomas Luther, Chris Reutelingsperger, Pablo Garcia de Frutos, Robert Frithiof, Gerry A F Nicolaes, Joram Huckriede, Sara Bülow Anderberg, Albert Morales, Femke de Vries, Michael Hultström, Anders Bergqvist, José T Ortiz-Pérez, Jan Willem Sels, Kanin Wichapong, Miklos Lipcsey, Marcel van de Poll, Anders Larsson, Tomas Luther, Chris Reutelingsperger, Pablo Garcia de Frutos, Robert Frithiof, Gerry A F Nicolaes
Abstract
Coronavirus disease 19 (COVID-19) presents with disease severities of varying degree. In its most severe form, infection may lead to respiratory failure and multi-organ dysfunction. Here we study the levels and evolution of the damage associated molecular patterns (DAMPS) cell free DNA (cfDNA), extracellular histone H3 (H3) and neutrophil elastase (NE), and the immune modulators GAS6 and AXL in relation to clinical parameters, ICU scoring systems and mortality in patients (n = 100) with severe COVID-19. cfDNA, H3, NE, GAS6 and AXL were increased in COVID-19 patients compared to controls. These measures associated with occurrence of clinical events and intensive care unit acquired weakness (ICUAW). cfDNA and GAS6 decreased in time in patients surviving to 30 days post ICU admission. A decrease of 27.2 ng/mL cfDNA during ICU stay associated with patient survival, whereas levels of GAS6 decreasing more than 4.0 ng/mL associated with survival. The presence of H3 in plasma was a common feature of COVID-19 patients, detected in 38% of the patients at ICU admission. NETosis markers cfDNA, H3 and NE correlated well with parameters of tissue damage and neutrophil counts. Furthermore, cfDNA correlated with lowest p/f ratio and a lowering in cfDNA was observed in patients with ventilator-free days.
Conflict of interest statement
The authors declare no competing interests.
© 2021. The Author(s).
Figures
References
- Pedersen SF, Ho YC. SARS-CoV-2: A storm is raging. J. Clin. Invest. 2020;130:2202–2205. doi: 10.1172/JCI137647.
- Novel Coronavirus Pneumonia Emergency Response Epidemiology T The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151.
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775–1776.
- COVID-NET: COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention. . Accessed 17 July 2021.
- Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052. doi: 10.1001/jama.2020.6775.
- Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur. Respir. J. 2020;55(5):2001227. doi: 10.1183/13993003.01227-2020.
- Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes Metab. Syndr. 2020;14(5):1133–1142. doi: 10.1016/j.dsx.2020.07.005.
- WHO Director-General’s statement on the advice of the IHR Emergency Committee on Novel Coronavirus. (2020).
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768.
- Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845–854. doi: 10.1182/blood-2017-10-804096.
- Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–1535. doi: 10.1126/science.1092385.
- Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. J. Thromb. Haemost. 2020;18:2110–2117. doi: 10.1111/jth.14981.
- Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U S A. 2010;107(36):15880–15885. doi: 10.1073/pnas.1005743107.
- Porto BN, Stein RT. Neutrophil extracellular traps in pulmonary diseases: Too much of a good thing? Front. Immunol. 2016;7:311. doi: 10.3389/fimmu.2016.00311.
- Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, van Rooijen N, Chow VT. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 2011;179(1):199–210. doi: 10.1016/j.ajpath.2011.03.013.
- Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair CN, Weber A, Barnes BJ, Egeblad M, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:138999.
- Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179. doi: 10.1182/blood.2020007008.
- Wong JJM, Leong JY, Lee JH, Albani S, Yeo JG. Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Ann. Transl. Med. 2019;7(19):504. doi: 10.21037/atm.2019.09.28.
- Silvestre-Roig C, Braster Q, Wichapong K, Lee EY, Teulon JM, Berrebeh N, Winter J, Adrover JM, Santos GS, Froese A, et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature. 2019;569(7755):236–240. doi: 10.1038/s41586-019-1167-6.
- Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze AE, van Mierlo GJ, Eerenberg AJ, Lammle B, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit. Care Med. 2003;31(7):1947–1951. doi: 10.1097/01.CCM.0000074719.40109.95.
- Dau T, Sarker RS, Yildirim AO, Eickelberg O, Jenne DE. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors. Nat. Commun. 2015;6:6722. doi: 10.1038/ncomms7722.
- Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu. Rev. Immunol. 2010;28:321–342. doi: 10.1146/annurev-immunol-030409-101311.
- Silk E, Zhao H, Weng H, Ma D. The role of extracellular histone in organ injury. Cell Death Dis. 2017;8(5):e2812. doi: 10.1038/cddis.2017.52.
- Nowak D, Piasecka G, Hrabec E. Chemotactic activity of histones for human polymorphonuclear leukocytes. Exp. Pathol. 1990;40(2):111–116. doi: 10.1016/S0232-1513(11)80329-4.
- Sun M, Jiang X, Jin Y, Yang H, Chen C, Lyu X, Wen Z. Extracellular histones are involved in lipopolysaccharide-induced alveolar macrophage injury by activating the TWIK2-NLRP3 pathway. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(2):194–198.
- Kordbacheh F, O'Meara CH, Coupland LA, Lelliott PM, Parish CR. Extracellular histones induce erythrocyte fragility and anemia. Blood. 2017;130(26):2884–2888. doi: 10.1182/blood-2017-06-790519.
- Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, Wang SS, Brohi K, Kipar A, Yu W, et al. Circulating histones are mediators of trauma-associated lung injury. Am. J. Respir. Crit. Care Med. 2013;187(2):160–169. doi: 10.1164/rccm.201206-1037OC.
- Collier DM, Villalba N, Sackheim A, Bonev AD, Miller ZD, Moore JS, Shui B, Lee JC, Lee FK, Reining S, et al. Extracellular histones induce calcium signals in the endothelium of resistance-sized mesenteric arteries and cause loss of endothelium-dependent dilation. Am. J. Physiol. Heart Circ. Physiol. 2019;316(6):H1309–H1322. doi: 10.1152/ajpheart.00655.2018.
- Zhang Y, Guan L, Yu J, Zhao Z, Mao L, Li S, Zhao J. Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome. Respir. Res. 2016;17(1):155. doi: 10.1186/s12931-016-0472-y.
- Meng W, Paunel-Gorgulu A, Flohe S, Hoffmann A, Witte I, MacKenzie C, Baldus SE, Windolf J, Logters TT. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Crit. Care. 2012;16(4):R137. doi: 10.1186/cc11442.
- Camicia G, Pozner R, de Larranaga G. Neutrophil extracellular traps in sepsis. Shock. 2014;42(4):286–294. doi: 10.1097/SHK.0000000000000221.
- Thulborn SJ, Mistry V, Brightling CE, Moffitt KL, Ribeiro D, Bafadhel M. Neutrophil elastase as a biomarker for bacterial infection in COPD. Respir. Res. 2019;20(1):170. doi: 10.1186/s12931-019-1145-4.
- Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, Dicker A, Wrobel K, Elborn JS, Walker B, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am. J. Respir. Crit. Care Med. 2017;195(10):1384–1393. doi: 10.1164/rccm.201605-1027OC.
- Muhlebach MS, Clancy JP, Heltshe SL, Ziady A, Kelley T, Accurso F, Pilewski J, Mayer-Hamblett N, Joseloff E, Sagel SD. Biomarkers for cystic fibrosis drug development. J. Cyst Fibros. 2016;15(6):714–723. doi: 10.1016/j.jcf.2016.10.009.
- Stockley R, De Soyza A, Gunawardena K, Perrett J, Forsman-Semb K, Entwistle N, Snell N. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis. Respir. Med. 2013;107(4):524–533. doi: 10.1016/j.rmed.2012.12.009.
- van der Meer JH, van der Poll T. van 't Veer C: TAM receptors, Gas6, and protein S: Roles in inflammation and hemostasis. Blood. 2014;123(16):2460–2469. doi: 10.1182/blood-2013-09-528752.
- Lemke G. Phosphatidylserine is the signal for TAM receptors and their ligands. Trends Biochem. Sci. 2017;42(9):738–748. doi: 10.1016/j.tibs.2017.06.004.
- Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau AD, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood. 2008;111(8):4096–4105. doi: 10.1182/blood-2007-05-089565.
- Salmi L, Gavelli F, Patrucco F, Caputo M, Avanzi GC, Castello LM. Gas6/TAM axis in sepsis: Time to consider its potential role as a therapeutic target. Dis Mark. 2019;2019:6156493.
- Ekman C, Linder A, Akesson P, Dahlback B. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit. Care. 2010;14(4):R158. doi: 10.1186/cc9233.
- Stalder G, Que YA, Calzavarini S, Burnier L, Kosinski C, Ballabeni P, Roger T, Calandra T, Duchosal MA, Liaudet L, et al. Study of early elevated Gas6 plasma level as a predictor of mortality in a prospective cohort of patients with sepsis. PLoS ONE. 2016;11(10):e0163542. doi: 10.1371/journal.pone.0163542.
- Yeh LC, Huang PW, Hsieh KH, Wang CH, Kao YK, Lin TH, Lee XL. Elevated plasma levels of Gas6 are associated with acute lung injury in patients with severe sepsis. Tohoku J. Exp. Med. 2017;243(3):187–193. doi: 10.1620/tjem.243.187.
- Gibot S, Massin F, Cravoisy A, Dupays R, Barraud D, Nace L, Bollaert PE. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit. Care. 2007;11(1):R8. doi: 10.1186/cc5158.
- Borgel D, Clauser S, Bornstain C, Bieche I, Bissery A, Remones V, Fagon JY, Aiach M, Diehl JL. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit. Care Med. 2006;34(1):219–222. doi: 10.1097/01.CCM.0000195014.56254.8A.
- Shibata T, Makino A, Ogata R, Nakamura S, Ito T, Nagata K, Terauchi Y, Oishi T, Fujieda M, Takahashi Y, et al. Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization. J. Clin. Invest. 2020;130:3021–3037. doi: 10.1172/JCI125505.
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brunink S, Schneider J, Schmidt ML, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
- Breitbach S, Tug S, Helmig S, Zahn D, Kubiak T, Michal M, Gori T, Ehlert T, Beiter T, Simon P. Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS ONE. 2014;9(3):e87838. doi: 10.1371/journal.pone.0087838.
- Xue X, Teare MD, Holen I, Zhu YM, Woll PJ. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin. Chim. Acta. 2009;404(2):100–104. doi: 10.1016/j.cca.2009.02.018.
- Wildhagen KC, Wiewel MA, Schultz MJ, Horn J, Schrijver R, Reutelingsperger CP, van der Poll T, Nicolaes GA. Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients. Thromb. Res. 2015;136(3):542–547. doi: 10.1016/j.thromres.2015.06.035.
- van Smaalen TC, Beurskens DM, Hoogland ER, Winkens B, Christiaans MH, Reutelingsperger CP, van Heurn LW, Nicolaes GA. Presence of cytotoxic extracellular histones in machine perfusate of donation after circulatory death kidneys. Transplantation. 2017;101(4):e93–e101. doi: 10.1097/TP.0000000000001590.
- Schoenfeld DA, Bernard GR, Network A. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit. Care Med. 2002;30(8):1772–1777. doi: 10.1097/00003246-200208000-00016.
- Mikacenic C, Moore R, Dmyterko V, West TE, Altemeier WA, Liles WC, Lood C. Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia. Crit. Care. 2018;22(1):358. doi: 10.1186/s13054-018-2290-8.
- Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Invest. 2020;130(11):6151–6157. doi: 10.1172/JCI141374.
- Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur. J. Pharmacol. 2002;451(1):1–10. doi: 10.1016/S0014-2999(02)02182-9.
- Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438–e440. doi: 10.1016/S2352-3026(20)30145-9.
- Ni J, Lin M, Jin Y, Li J, Guo Y, Zhou J, Hong G, Zhao G, Lu Z. Gas6 attenuates sepsis-induced tight junction injury and vascular endothelial hyperpermeability via the Axl/NF-kappaB signaling pathway. Front. Pharmacol. 2019;10:662. doi: 10.3389/fphar.2019.00662.
- Ekman C, Stenhoff J, Dahlback B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J. Thromb. Haemost. 2010;8(4):838–844. doi: 10.1111/j.1538-7836.2010.03752.x.
Source: PubMed